These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21982641)

  • 21. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
    Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
    Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
    Cremers EM; Westers TM; Alhan C; Cali C; Visser-Wisselaar HA; Chitu DA; van der Velden VH; Te Marvelde JG; Klein SK; Muus P; Vellenga E; de Greef GE; Legdeur MC; Wijermans PW; Stevens-Kroef MJ; Silva-Coelho PD; Jansen JH; Ossenkoppele GJ; van de Loosdrecht AA;
    Haematologica; 2017 Feb; 102(2):320-326. PubMed ID: 27658438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes.
    Bacher U; Haferlach C; Kröger N; Schnittger S; Kern W; Wiedemann B; Zander AR; Haferlach T
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):1-11. PubMed ID: 20053328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
    Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
    Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of flow cytometry in diagnostics of myelodysplastic syndromes--beyond the WHO 2008 classification.
    Porwit A
    Semin Diagn Pathol; 2011 Nov; 28(4):273-82. PubMed ID: 22195405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.
    Porwit A; van de Loosdrecht AA; Bettelheim P; Brodersen LE; Burbury K; Cremers E; Della Porta MG; Ireland R; Johansson U; Matarraz S; Ogata K; Orfao A; Preijers F; Psarra K; Subirá D; Valent P; van der Velden VH; Wells D; Westers TM; Kern W; Béné MC
    Leukemia; 2014 Sep; 28(9):1793-8. PubMed ID: 24919805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.
    van de Loosdrecht AA; Ireland R; Kern W; Della Porta MG; Alhan C; Balleisen JS; Bettelheim P; Bowen DT; Burbury K; Eidenschink L; Cazzola M; Chu SS; Cullen M; Cutler JA; Dräger AM; Feuillard J; Fenaux P; Font P; Germing U; Haase D; Hellström-Lindberg E; Johansson U; Kordasti S; Loken MR; Malcovati L; te Marvelde JG; Matarraz S; Milne T; Moshaver B; Mufti GJ; Nikolova V; Ogata K; Oelschlaegel U; Orfao A; Ossenkoppele GJ; Porwit A; Platzbecker U; Preijers F; Psarra K; Richards SJ; Subirá D; Seymour JF; Tindell V; Vallespi T; Valent P; van der Velden VH; Wells DA; de Witte TM; Zettl F; Béné MC; Westers TM
    Leuk Lymphoma; 2013 Mar; 54(3):472-5. PubMed ID: 22916713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia.
    Kussick SJ; Fromm JR; Rossini A; Li Y; Chang A; Norwood TH; Wood BL
    Am J Clin Pathol; 2005 Aug; 124(2):170-81. PubMed ID: 16040286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometry in myelodysplastic syndromes: report from a working conference.
    Loken MR; van de Loosdrecht A; Ogata K; Orfao A; Wells DA
    Leuk Res; 2008 Jan; 32(1):5-17. PubMed ID: 17576013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment.
    Burbury KL; Westerman DA
    Leuk Lymphoma; 2014 Apr; 55(4):749-60. PubMed ID: 23808833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The flow cytometry myeloid progenitor count: A reproducible parameter for diagnosis and prognosis of myelodysplastic syndromes.
    Johansson U; McIver-Brown N; Cullen M; Duetz C; Dunlop A; Oelschlägel U; Psarra K; Subirá D; Westers TM
    Cytometry B Clin Cytom; 2023 Mar; 104(2):115-127. PubMed ID: 34931733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of flow cytometry to the analysis of the myelodysplastic syndrome.
    Miller DT; Stelzer GT
    Clin Lab Med; 2001 Dec; 21(4):811-28. PubMed ID: 11770289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world.
    Grille S; Iastrebner M; Lorand-Metze I; van der Velden VHJ; Ikoma MRV; Vidal-Senmache G; Colado E; Rabelo-Carrasco LJ; Blanco A; Huamán-Garaicoa F; O'Connor JE; Cao Pochintesta C; Jensen E; Bacal NS; Díaz L; Lens D
    Leuk Res; 2019 Apr; 79():69-74. PubMed ID: 30773246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
    Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
    Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.